Skip to main content
. 2023 Oct 11;11:goad059. doi: 10.1093/gastro/goad059

Table 1.

Characteristics of participants by tertiles of the predicted pro-inflammatory hs-CRP score

Characteristic Tertiles of the predicted pro-inflammatory hs-CRP score
Tertile 1 Tertile 2 Tertile 3
(n = 358) (n = 359) (n = 359)
Predicted pro-inflammatory hs-CRP score, mean ± SD –3.1 ± 0.1 –2.7 ± 0.1 –2.4 ± 0.1
NAFLD cases, n (%) 34 (9.5) 81 (22.6) 205 (57.1)
Females, n (%) 299 (83.5) 211 (58.8) 99 (27.6)
 Postmenopausal women, n (%) 208 (69.6) 81 (38.4) 17 (17.2)
Age (years), mean ± SD 45.7 ± 7.2 52.4 ± 7.6 56.7 ± 9.6
Highest education completed
 College graduate or above, n (%) 310 (86.6) 268 (74.7) 264 (73.5)
Current smoking, n (%) 9 (2.5) 27 (7.5) 94 (26.2)
Alcohol intake (g/d), mean ± SD 2.2 ± 3.3 3.8 ± 4.9 4.3 ± 5.9
Physical activity (MET-minutes/week), mean ± SD 1,271.8 ± 2,920.7 1,191.5 ± 2,073.3 1,267.5 ± 2,654.1
 ≥840 MET-minutes/week, n (%) 130 (36.3) 131 (36.5) 127 (35.4)
BMI (kg/m2), mean ± SD 20.3 ± 1.7 22.9 ± 1.5 25.8 ± 2.5
 BMI ≥ 23 kg/m2, n (%) 21 (0.3) 172 (9.8) 323 (60.5)
hs-CRP (mg/dL), mean ± SD 0.1 ± 0.2 0.1 ± 0.3 0.2 ± 0.3
Waist circumference (cm), mean ± SD 76.0 ± 5.3 82.9 ± 4.7 90.8 ± 6.6
Systolic blood pressure (mmHg), mean ± SD 109.3 ± 11.8 114.7 ± 12.9 120.1 ± 13.2
Diastolic blood pressure (mmHg), mean ± SD 69.2 ± 9.2 74.0 ± 9.8 76.9 ± 10.1
 Hypertensivesa, n (%) 22 (6.2) 68 (18.9) 134 (37.3)
Fasting plasma glucose (mg/dL), mean ± SD 86.2 ± 13.3 93.7 ± 14.6 100.9 ± 19.5
 Diabetes mellitusb, n (%) 7 (2.0) 26 (7.2) 66 (18.4)

hs-CRP: high-sensitivity C-reactive protein.

Continuous variables are presented as mean ± SD and categorical variables are presented as n (%); SD: standard deviation; NAFLD: non-alcoholic fatty liver disease; BMI: body mass index; hs-CRP: high-sensitivity C-reactive protein; MET: the metabolic equivalent of task.

a

Hypertension was defined as systolic blood pressure of ≥140 mmHg, diastolic blood pressure of ≥90 mmHg, or the use of antihypertensive medication.

b

Diabetes was defined as fasting blood glucose value of ≥126 mg/dL, a glycated hemoglobin level of ≥6.5%, or a history of using glucose-lowering medications.